Remifentanil

CHEMBL1005 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

376.4 g/mol

LogP

1.9

Phase

4

An ultra-short-acting opioid analgesic used during surgery and other medical procedures for pain control and sedation, with effects that dissipate within minutes of stopping the infusion. Its rapid onset and offset make it ideal for procedures requiring precise control of pain relief.

Berat Molekul

376,4000 g/mol

LogP

1,90

TPSA

76,20 Å²

Lipinski RO5

Lulus

Area Terapeutik

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Benign Prostatic Hyperplasia Glaucoma Cardiovascular Disease Respiratory Disease Pain Management Non-Small Cell Lung Cancer Rheumatoid Arthritis Asthma Chronic Obstructive Pulmonary Disease Parkinson's Disease Epilepsy Generalized Anxiety Disorder Obstetrics & Gynecology Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Stroke Obesity Type 2 Diabetes Hypertension Breast Cancer Chronic Pain Atrial Fibrillation Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1

InChI

InChI=1S/C20H28N2O5/c1-4-17(23)22(16-8-6-5-7-9-16)20(19(25)27-3)11-14-21(15-12-20)13-10-18(24)26-2/h5-9H,4,10-15H2,1-3H3

Molecular Formula

C20H28N2O5

HBD / HBA

- / 6

Ikatan yang Dapat Dirotasi

9

Atom Berat

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

An ultra-short-acting opioid analgesic used during surgery and other medical procedures for pain control and sedation, with effects that dissipate within minutes of stopping the infusion. Its rapid onset and offset make it ideal for procedures requiring precise control of pain relief.

Yes, Remifentanil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1005. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 60815. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Remifentanil di PillFYI

Struktur

Data Cepat

Rumus: C20H28N2O5
Sinonim: 1

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.